Diality Inc., a medical device company based in Irvine, Calif., has announced the appointment of Ravi Parthasarathy as its new Chief Technology Officer. Parthasarathy brings with him extensive experience in product development team leadership, having most recently worked at ICU Medical as the Vice President of Device Engineering. Prior to that, he held leadership positions at Baxter Healthcare, Motorola, Siemens Medical Systems, and General Motors.
Osman Khawar, M.D., the CEO of Diality, expressed his excitement about Parthasarathy joining the team, stating that his expertise and alignment with Diality’s mission, vision, and values make him a perfect fit for the company. Additionally, as Diality continues to grow, Clayton Poppe will transition into the role of Chief Scientific Officer (CSO), overseeing the research, quality, and regulatory functions.
Parthasarathy expressed his enthusiasm about joining Diality and citing the company’s mission of improving the lives of those affected by kidney disease as a significant motivation. The Moda-flxTM Hemodialysis System developed by Diality is a patient-centric solution that aims to empower healthcare professionals to make choices that benefit patients and their clinical practice. For more information about Diality and its products visit www.diality.com or find them on LinkedIn. For media inquiries please contact Sam Choinski at schoinski@pazangahealth.com or (860) 301-5058